Vaccine Adjuvants Market to Reach USD 5.43 Billion by 2032 Due to Increasing Demand for Enhanced Vaccine Efficacy and Global Immunization Programs – SNS Insider
SNS Insider Reveals Robust Expansion in the U.S. Vaccine Adjuvants Market—Valued at USD 1.25 Billion in 2024—Capturing Over 86% of…